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The Sterol Regulatory Element Binding Proteins (SREBP) transcription factors 44 belong to the basic helix-loop-helix leucine zipper family of DNA binding proteins. 45
The three isoforms identified so far in mammalian tissues are coded by two distinct 46 genes, Srebf1 and Srebf2, and vary in structure, regulation, and functions (14) . 47 SREBP-1a and SREBP-1c proteins are produced by alternative promoter usage of 48 the SREBF1 gene and are key actors of the regulation of genes related to lipid 49 metabolism, especially those involved in lipogenesis and triglyceride deposition. In 50 contrast, SREBP-2 has been more closely associated to cholesterol synthesis and 51 accumulation (20, 52) . 52
In agreement with these known functions, the SREBP-1 proteins are strongly 53 expressed in tissues with high lipogenic capacities, like liver and adipose tissues. 54
However, significant expression has been also reported in skeletal muscle, both in 55 vivo and in vitro in cultured muscle cells (12, 13, 18) . In muscle, SREBP-1 expression 56 is induced by activation of the PI3K/Akt and the MAP kinase pathways by insulin and 57 growth factors (6, 12, 18, 28, 38) , suggesting additional functions of these 58 transcription factors in a tissue with a low rate of lipid synthesis. Using microarray 59 analysis to characterize the role of SREBP-1a and -1c in skeletal muscle, we have 60 recently identified some of their potential target genes in primary cultures of human 61 myotubes overexpressing SREBP-1a or . In this study we found that 62 SREBP-1a and -1c regulate more than one thousand genes, indicating that they are 63 potentially involved in the regulation of a large variety of biological functions in 64 muscle cells. Quite unexpectedly, we observed a dramatic reduction in the 65 expression of a number of muscle-specific genes and markers of muscle 66 BHLHB3. As a control, the contralateral tibialis anterior muscles were also injected 138 with 10 10 infectious units of recombinant adenovirus expressing GFP. Mice were 139 sacrificed seven days after injection. Tibialis anterior muscle was removed and 140 immediately snap-frozen in liquid nitrogen. Ten-micron sections were cut and every 141 tenth section collected onto glass slides for examination under fluorescence 142 illumination using an Axiovert 200 microscope, an Axiocam MRm camera and 143 experiments were performed according to (12) . After transfer, gels were stained with 163 Coomassie Blue. Membranes were then incubated overnight at 4°C with the following 164 specific primary antibodies : anti-SREBP1 (H160), anti-MYOD1 (M316), anti-MEF2C 165 (E17), anti-MYOG (M225), anti-TNNI1 (C-19), and anti-TNNI2 (C-19) from Santa 166
Cruz Biotechnology, (Santa Cruz, CA, USA) ; anti-BHLHB2 (M01; 5B1) and anti-167 BHLHB3 from Abnova (M01; 4H6) (Taipei, Taiwan) . 168
The signal was detected using a horse-radish peroxidase-conjugated secondary 169 antibody and revealed with the enhanced chemiluminescence system (Pierce, 170
Rockford, IL, USA). Signal was quantified using NIH ImageJ software. Intensity of 171
Coomassie Blue staining was used to normalize the total amount of proteins. 172
173
Quantification of mRNAs by real-time RT-PCR. Total RNA was isolated using the 174
Trizol reagent (Invitrogen, Courtaboeuf, France) according to manufacturer's 175 instructions. First-strand cDNAs were synthesized from 500 ng of total RNAs in the 176 presence of 100 U of Superscript II (Invitrogen) and a mixture of random hexamers 177 and oligo(dT) primers (Promega). Real-time PCR assays were performed with Rotor-178 Bioinformatics, Karolinska Institute, Stockholm, Sweden) (Zabarovsky ER, 2000) . 194
The -408/+75 (according to the transcription starting site) fragment was then 195 subcloned into the luciferase reporter gene vector pGL3-Enhancer (Promega) to 196 obtain pB21 (-408/+75). The -951/-407 fragment was generated by PCR and ligated 197 into pB21 to obtain pB22 (-951/+75). The constructs pB23 (-264/+75) and pB26 (-198 187/+75) were generated by deletion of pB21. To obtain pB32, two genomic 199 fragments, corresponding to the -940/-289 and -524/+238 regions of the BHLHB3 200 gene, were generated by PCR and combined to obtain the -940/+238 fragment into 201 pGL3-E vector. Mutations of the SRE motifs were performed as described (12) . 202
Mutagenesis was performed to replace bases 2, 4 and 6 of each identified SRE by 203 thymidine residues (Quick Change Mutagenesis Kit, Qiagen). 204
Transfection studies were carried out on myoblasts or myotubes plated in 12-well 205 plates as previously described (12 
Results
223
SREBP-1a and -1c down-regulate muscle specific genes in human myotubes 224
We recently reported that adenovirus-mediated expression of the mature nuclear 225 forms of either SREBP-1a or SREBP-1c triggered the regulation of more than 1300 226 genes in human differentiated myotubes (43). Using FATiGO (www.babelomics.es) 227 to analyze these microarray data, three Gene Ontology (GO) classes showed 228 significant over-representation in the list of genes found to be regulated in the 229 presence of SREBP-1 proteins when compared to their representation in the human 230 genome: "muscle contraction" (GO 0006936, adjusted p value = 2.84 e-5), the 231 subclass "striated muscle contraction" (GO 0006941, adjusted p value = 2.46 e-5) 232
and "muscle development" (GO 0007517, adjusted p value = 6.27 e-5). The 233 corresponding genes with fold-change values upon SREBP-1a or -1c expression are 234 listed in Table 1 . These genes encode transcription factors involved in muscle 235 differentiation (i.e. MYOD1, MYOG, MEF2C), as well as a large number of muscle 236 contraction proteins (i.e. heavy and light chains of myosin, troponins, titin). Most of 237 them were down-regulated in the presence of SREBP-1a or -1c (28 of 38 for "muscle 238 contraction" and 26 of 39 for "muscle development"). 239
240
Transcriptional repressors BHLHB2 and BHLHB3 are SREBP-1 target genes 241
The SREBP-1s microarray data obtained on differentiated myotubes contain two 242 bHLH family members that are up regulated upon SREBP-1s overexpression. The 243 transcriptional repressors BHLHB2 and BHLHB3 show an about 2-fold increase in 244 their expression levels (supplementary data of (43)). Since recent report indicated 245 that BHLHB3 is a potent inhibitor of muscle cell differentiation (2), we decided to 246 focus on these factors. To assess SREBP-1a and -1c effects on BHLHB2 and 247 BHLHB3 expression, we overexpressed nuclear SREBP-1 in human primary muscle 248 cells at both myoblasts and myotubes stages, and also in vivo in mouse tibialis 249 anterior muscle. As shown in figure 1A and 1B, overexpression of SREBP-1 in 250 myoblasts, myotubes and mouse muscle induced significant increases in both 251 BHLHB2 and BHLHB3 mRNA and proteins levels in all situations. As a control, we 252 verified that overexpression of ADD1-DN, a dominant-negative mutant of SREBP-1 253 
Overexpression of BHLHB2and BHLHB3 in myotubes 283
We performed microarray analysis in human primary myotubes overexpressing either 284 BHLHB2 or BHLHB3 after adenovirus infection. FATIGO analysis revealed that the 285 same biological processes identified after SREBP-1 overexpression ("muscle 286 contraction", "striated muscle contraction" and "muscle development") were 287 significantly enriched (adjusted p values < 0.05) in the lists of regulated genes. We 288 found that BHLHB2 and BHLHB3 down-regulated 69 and 65 genes with muscle 289 annotation, respectively (Table 2) . Furthermore, the comparison with the SREBP-1 290 microarray data showed that a large proportion (34%) of the muscle-specific genes 291 that were down-regulated by SREBP-1 expression were also down-regulated by 292 BHLHB2/B3 overexpression. 293
Overlapping down-regulated genes for the two GO biological processes "muscle 294 development" and "muscle contraction" are represented in Figure 3 . Among genes 295 involved in muscle differentiation, MYOD1, MYOG and MEF2C show a decrease in 296 their expression upon both SREBP-1 and BHLHB2/B3 overexpression. 297
SREBP-1a and -1c inhibit myoblast differentiation 299
Because the expression of specific markers of muscle differentiation was decreased 300 in myotubes overexpressing SREBP-1, we first examined the expression of the four 301 studied transcription factors during the differentiation of human primary muscle cells 302 (Figure 4 A) . All four present a similar pattern of expression with an increase during 303 proliferation and a decrease after induction of differentiation. To further examine 304 whether SREBP-1 could directly affect myogenic differentiation, primary human 305 myoblasts were thus infected with recombinant adenoviruses expressing GFP, 306 SREBP-1a, or SREBP-1c. After 48 hours, SREBP-1 expressing myoblasts showed a 307 dramatic decrease in MYOD1, MYOG and MEF2C levels ( Figure 4B ). When the cells 308 were induced to differentiate (medium change and serum starvation) for five days, 309
only Ad-GFP infected cells underwent differentiation ( Figure 4C ). The presence of 310
SREBP-1 totally blocked the differentiation of myoblasts into myotubes. 311
To determine the implication of BHLHB2 and/or BHLHB3 in this process, human 312 primary myoblasts were infected with recombinant adenovirus expressing either 313 BHLHB2 or BHLHB3. As shown in Figure 4D , 48 hours of BHLHB2 and BHLHB3 314 overexpression also induced a marked decrease in the expression of muscle 315 regulatory factors (MYOD1, MYOG and MEF2C). After 5 days of differentiation, we 316 observed a dramatic decrease in the number and the size of polynucleated cells, 317 correlated with the reduced expression of myogenin and troponin ( figure 4E) . 318
To finally demonstrate the involvement of BHLHB2 and BHLHB3 in the effects of 319 SREBP-1 on myoblasts, SREBP-1 overexpressing myoblasts were transfected with 320 siRNA against GFP (control), BHLHB2, or BHLHB3, resulting in a partial gene 321 extinction of BHLHB2 and BHLHB3 expression ( Figure 5A ). As shown in Figure 5B , 322 inhibition of either BHLHB2 or BHLHB3 can restore, at least partially, the expression 323 of MYOD1, MYOG and MEF2C proteins that are down-regulated upon SREBP-1 324 overexpression. Depletion of BHLHB2/B3 was sufficient to restore differentiation and 325 myogenin and troponin expression in cells overexpressing SREBP-1 ( Figure 5C ). 326
Altogether, these data led us to propose that SREBP-1a and -1c block myoblasts to 327 myotubes differentiation via an increase in BHLHB2 and BHLHB3 expression, the 328 latter repressing the expression of MRFs. 329
330
SREBP-1a and -1c induce atrophy of differentiated myotubes 331
We next examined the consequences of nuclear accumulation of SREBP-1 proteins 332 in differentiated muscle cells. To confirm and expand the microarray data, we 333 measured the expression levels of several transcription factors and sarcomeric 334 protein genes using quantitative PCR in primary myotubes overexpressing the 335 SREBP-1 factors for 48 hours. Figure 6 shows that both SREBP-1a and 1c 336 decreased the expression of myogenic regulatory factors (MYOD1, MYOG, and 337 MEF2C) ( Figure 6A ). A significant reduction in the mRNA levels of muscle contractile 338 proteins (TTN, TNNI1, TNNI2, and MYL1) was also observed. These data were 339 further confirmed at the protein level ( Figure 6B ). Therefore, the mature forms of 340 SREBP-1a and -1c clearly induced a dramatic decrease in the expression of major 341 actors of skeletal muscle function, involved in either formation or contractility. 342
Direct observation of myotubes overexpressing SREBP-1 showed a decrease in cell 343 surfaces. Troponin immunostaining confirmed a considerable reduction in sarcomeric 344 protein content ( Figure 6C ). Cell sizes measurements showed that SREBP-1 proteins 345
induced an approximately 6-fold decrease in cell surface ( Figure 6D ). These 346 observations indicated thus that nuclear accumulation of SREBP-1 led to myotube 347 atrophy, with a severe decrease in the expression of muscle regulatory factors and 348 sarcomeric proteins. To assess whether the observed SREBP1-induced atrophy 349 involved known atrophic factors, we measured the mRNA levels of FBXO32 350 (Atrogin1), SMURF1 (MuRF-1/TRIM63) and FOXO1. As shown in Figure 6A , with the 351 exception of SMURF1, the expression of these factors was reduced in the presence 352 of SREBP-1a and -1c. The up-regulation of SMURF1 mRNA however, is in 353 agreement with our previous microarray data (43). To confirm the involvement of BHLHB2 and BHLHB3 in the atrophic effect of 364 SREBP-1 on differentiated myotubes, SREBP-1 overexpressing myotubes were 365 transfected with siRNA against GFP, BHLHB2, or BHLHB3. As shown in Figure 7D , 366 gene extinction of either BHLHB2 or BHLHB3 restores the expression of troponin. 367
Depletion of BHLHB2/B3 also restored, at least partially, the size of myotubes, with a 368 greater effect of BHLHB3 silencing ( Figure 7E ). 369 370 Altogether, these data indicated that, as observed for inhibition of myoblast 371 differentiation, the transcriptional repressors BHLHB2 and BHLHB3 are directly 372 involved in the atrophy induced by SREBP-1 in differentiated myotubes. 373 374
SREBP-1a and -1c promote skeletal muscle atrophy in vivo 375
To investigate the effects of SREBP-1 factors on muscle phenotype in vivo, we 376 overexpressed SREBP-1a or SREBP-1c in limb muscle of mice using recombinant 377 adenovirus. Adenoviruses expressing either GFP only, or both SREBP-1a and GFP 378 (or SREBP-1c and GFP) were generated using dual expression properties of 379 constructs containing an IRES element (26). Twelve week-old BALB/c male mice 380 were separated into two groups and adenoviral suspensions were injected in tibialis 381 anterior muscle with 10 10 infectious units of recombinant adenoviruses expressing 382 only GFP (Ad-GFP) in the left limb of all animals and either SREBP-1a and GFP (Ad-383 1a/GFP, first group) or SREBP-1c and GFP (Ad-1c/GFP, second group) in the right 384 limb. Animals were sacrificed seven days after injections and tibialis anterior muscles 385 were removed for analysis. When comparing the two groups, no differences were 386 found in GFP-only expressing muscles of the left limbs (weight, fiber sizes, and 387 fluorescence intensity); we thus considered the data concerning Ad-GFP infected 388 muscles as a unique set. As shown in Figure 8A , tibialis anterior weight showed a 389 significant decrease of 17.5% (SREBP-1a/GFP vs. GFP, n=7, p=0.001) and 18.6% 390 GFP-only and SREBP-1/GFP expressing muscles, the latter presenting a marked 401 displacement of distribution towards smaller sizes of fibers ( Figure 8C) . 402
Representative histological sections are shown in Figure 8D extensively studied in hepatocytes and in mouse liver. By activation of specific target 416 genes involved in lipogenesis, SREBP-1 increase triglycerides synthesis, and to a 417 lesser extent cholesterol synthesis (8, 20, 21, 47) . SREBP-1c was also shown to 418 mediate the action of insulin on the expression of lipogenic genes in liver (16). 419 SREBP-1 proteins are also expressed in skeletal muscle (13, 38, 39) and in cultured 420 muscle cells (12, 18) . In this report we identified a new role for these transcription 421 factors and demonstrated that both SREBP-1a and SREBP-1c can block myoblast to 422 myotube differentiation, and also induce myotube atrophy in vitro and in vivo. CACNG1  HRC  TNNI1  TNNI2  TNNT2  TNNT3   CHRNA1  MYBPC1  MYH2   MYBPH  SLC6A8  SSPN   CACNG1  HRC  TNNI1  TNNI2  TNNT2  TNNT3   MYL1  MYOD1   MEF2C  MRAS  CAV3  COL5A3  MYOG  SGCD  TEAD4  TNNT2   MYL1  MYOD1   MEF2C  MRAS  CAV3  COL5A3  MYOG  SGCD 
